Bionik Laboratories Corp. announced the appointment of Richard Russo, Jr. as Chief Executive Officer, previously served as Chief Financial Officer. appointment is effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 12 | |
-5.51% | 181B | |
+2.33% | 112B | |
-3.62% | 67.92B | |
+1.52% | 50.1B | |
+8.06% | 44.27B | |
+7.80% | 40.41B | |
+23.35% | 31.95B | |
+0.67% | 25.82B | |
+17.44% | 25.29B |
- Stock Market
- Equities
- BNKL Stock
- News Bionik Laboratories Corp.
- Bionik Laboratories Corp. Appoints Richard Russo as Chief Executive Officer